Imperial Innovations spins out heart disease prevention company

Spin-out

Imperial Innovations, the technology commercialisation arm of Imperial College London, has announced the formation of MyAction Ltd, a joint venture with Bromley MyTime, a leisure centre, to promote a community-based cardiovascular disease prevention programme.

The primary care trust NHS Westminster is the first to incorporate MyAction in its heart disease prevention programme. MyAction works by providing expert medical supervision to those at risk of developing cardiovascular disease and brings together GPs, cardiologists, nurses and physiotherapists.

MyAction transfers understanding of cardiovascular risk to primary care trusts and local authorities, and uses novel techniques to move care closer to home for patients who already have, or who are at risk of developing, cardiovascular disease. The company has developed infrastructure and technology to support these programmes, which can be used by participating organisations, and from which MyAction can capture data.

Pilot programmes have provided evidence that MyAction improves diet, increases physical activity, reduces obesity and belly fat, reduces blood pressure, reduces cholesterol and controls diabetes. Surveys show that 94 per cent of MyAction participants are highly satisfied with the programme.

Susan Searle, CEO of Imperial Innovations said, “MyAction has already proven its efficacy in lifestyle management, as a key component of its Healthy Hearts and Minds Programme, amongst patients with cardiovascular disease. It has the potential to be rolled out to multiple international markets, generating a long-term recurring income stream to its shareholders, by addressing a growing health problem.”